Results
|
4081.
|
Temporal trends, congener patterns, and sources of octa-, nona-, and decabromodiphenyl ethers (PBDE) and hexabromocyclododecanes (HBCD) in Swiss lake sediments. [electronic resource] by
- Kohler, Martin
- Zennegg, Markus
- Bogdal, Christian
- Gerecke, Andreas C
- Schmid, Peter
- Heeb, Norbert V
- Sturm, Michael
- Vonmont, Heinz
- Kohler, Hans-Peter E
- Giger, Walter
Producer: 20081024
In:
Environmental science & technology vol. 42
Availability: No items available.
|
|
4082.
|
|
|
4083.
|
|
|
4084.
|
|
|
4085.
|
|
|
4086.
|
|
|
4087.
|
|
|
4088.
|
|
|
4089.
|
The repair of critical-sized bone defects using expedited, autologous BMP-2 gene-activated fat implants. [electronic resource] by
- Betz, Oliver B
- Betz, Volker M
- Abdulazim, Ahmed
- Penzkofer, Rainer
- Schmitt, Bärbel
- Schröder, Christian
- Mayer-Wagner, Susanne
- Augat, Peter
- Jansson, Volkmar
- Müller, Peter E
Producer: 20100602
In:
Tissue engineering. Part A vol. 16
Availability: No items available.
|
|
4090.
|
Sports activities after medial unicompartmental knee arthroplasty Oxford III-what can we expect? [electronic resource] by
- Pietschmann, Matthias F
- Wohlleb, Lisa
- Weber, Patrick
- Schmidutz, Florian
- Ficklscherer, Andreas
- Gülecyüz, Mehmet F
- Safi, Elem
- Niethammer, Thomas R
- Jansson, Volkmar
- Müller, Peter E
Producer: 20130527
In:
International orthopaedics vol. 37
Availability: No items available.
|
|
4091.
|
|
|
4092.
|
|
|
4093.
|
|
|
4094.
|
|
|
4095.
|
|
|
4096.
|
Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2). [electronic resource] by
- English, Diana P
- Bellone, Stefania
- Cocco, Emiliano
- Bortolomai, Ileana
- Pecorelli, Sergio
- Lopez, Salvatore
- Silasi, Dan-Arin
- Schwartz, Peter E
- Rutherford, Thomas
- Santin, Alessandro D
Producer: 20140106
In:
American journal of obstetrics and gynecology vol. 209
Availability: No items available.
|
|
4097.
|
Taselisib, a selective inhibitor of PIK3CA, is highly effective on PIK3CA-mutated and HER2/neu amplified uterine serous carcinoma in vitro and in vivo. [electronic resource] by
- Lopez, Salvatore
- Schwab, Carlton L
- Cocco, Emiliano
- Bellone, Stefania
- Bonazzoli, Elena
- English, Diana P
- Schwartz, Peter E
- Rutherford, Thomas
- Angioli, Roberto
- Santin, Alessandro D
Producer: 20150129
In:
Gynecologic oncology vol. 135
Availability: No items available.
|
|
4098.
|
In vivo measurement of dose distribution in patients' lymphocytes: helical tomotherapy versus step-and-shoot IMRT in prostate cancer. [electronic resource] by
- Zwicker, Felix
- Swartman, Benedict
- Roeder, Falk
- Sterzing, Florian
- Hauswald, Henrik
- Thieke, Christian
- Weber, Klaus-Josef
- Huber, Peter E
- Schubert, Kai
- Debus, Jürgen
- Herfarth, Klaus
Producer: 20160125
In:
Journal of radiation research vol. 56
Availability: No items available.
|
|
4099.
|
HER2/neu gene amplification determines the sensitivity of uterine serous carcinoma cell lines to AZD8055, a novel dual mTORC1/2 inhibitor. [electronic resource] by
- English, Diana P
- Roque, Dana M
- Carrara, Luisa
- Lopez, Salvatore
- Bellone, Stefania
- Cocco, Emiliano
- Bortolomai, Ileana
- Schwartz, Peter E
- Rutherford, Thomas
- Santin, Alessandro D
Producer: 20140123
In:
Gynecologic oncology vol. 131
Availability: No items available.
|
|
4100.
|
|